VP

Vincent Picozzi

Physician · Virginia Mason Franciscan Health

Credentials: · · · · ·

History

Virginia Mason Franciscan Health
2026–Present

Stanford University
1982–1984
Internal Medicine
Brigham and Women's Hospital
1978–1979
Stanford University School of Medicine
1974–1978

Research

Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
New England Journal of Medicine · 1991 · 1,294 citations
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer
Journal of Clinical Oncology · 2015 · 501 citations
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket…
Annals of Oncology · 2021 · 354 citations

William Helton
11 papers
FR
Flavio Rocha
9 papers
RK
Richard Kozarek
9 papers
Adnan Alseidi
8 papers
Thomas Biehl
7 papers
Allyson Ocean
6 papers
Andrew Hendifar
6 papers
WT
William Traverso
6 papers
Andrea Wang-Gillam
5 papers
Russell Dorer
5 papers
AS
Alexander Starodub
4 papers
DA
David Aboulafia
4 papers

Clinical trials

Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer
Principal investigator · Unknown · Phase 1
Benaroya Research Institute
2018–2022
Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology
Principal investigator · Unknown · Phase 1
Benaroya Research Institute
2018–2023
A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer
Principal investigator · Completed · Phase 1, Phase 2
Kyntra Bio
2014–2021
A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer
Principal investigator · Completed · Phase 1
Kyntra Bio
2008–2014